Last SFr.3.99 CHF
Change Today -0.08 / -1.97%
Volume 41.7K
ADXN On Other Exchanges
Symbol
Exchange
ADXN is not on other exchanges.
As of 11:43 AM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark A. Geyer Ph.D.

Member of Scientific Advisory Board, Addex Therapeutics Ltd.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background*

Mark A. Geyer, Phd serves as Consultant of Addex Pharmaceuticals SA. A pioneer in the translational study of sensorimotor gating deficits in schizophrenia and related animal models, Dr. Geyer is the Director of the Basic Neuroscience Unit of the VISN 22 VA Administration's Mental Illness Research, Clinical, and Education Center that focuses on the treatment of schizophrenia. Dr. Geyer is a Professor of Psychiatry and Neurosciences at University of California, San Diego ...

Read Full Background

Corporate Headquarters*

12, chemin des Aulx
Geneva, Geneva 1228

Switzerland

Phone: 41 22 884 15 55
Fax: 41 22 884 15 56

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ADXN:SW SFr.3.99 CHF -0.08

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADDEX PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.